New Key Statistics Module, Z-Score and F-Score
OTCPK:INBP Key Ratios
| Market Cap $ M | 6.47 |
| Enterprise Value $ M | 8.01 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.35 |
| Price/Sales | 0.13 |
| Price/Free Cash Flow | 21.50 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 50.00 |
| EPS (TTM) $ | -0.01 |
| Beneish M-Score | -2.44 |
| 10-y EBITDA Growth Rate % | 2.80 |
| 5-y EBITDA Growth Rate % | -6.50 |
| y-y EBITDA Growth Rate % | -75.70 |
| EV-to-EBIT | -22.14 |
| EV-to-EBITDA | 14.98 |
| PEG | -- |
| Shares Outstanding M | 30.10 |
| Net Margin (%) | -0.76 |
| Operating Margin % | -0.76 |
| Pre-tax Margin (%) | -0.73 |
| Quick Ratio | 0.84 |
| Current Ratio | 2.93 |
| ROA % (ttm) | -1.47 |
| ROE % (ttm) | -2.05 |
| ROIC % (ttm) | -2.02 |
| Dividend Yield % | -- |
| Altman Z-Score | 1.20 |
INBP Number of Guru Trades
INBP Volume of Guru Trades
Gurus Latest Trades with OTCPK:INBP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:INBP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Integrated Biopharma Inc Insider Transactions
No Available Data
News about OTCPK:INBP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers